A detailed history of Hm Payson & CO transactions in Johnson & Johnson stock. As of the latest transaction made, Hm Payson & CO holds 384,073 shares of JNJ stock, worth $60.2 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
384,073
Previous 399,574 3.88%
Holding current value
$60.2 Million
Previous $58.4 Million 6.58%
% of portfolio
1.07%
Previous 1.06%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$145.48 - $167.38 $2.26 Million - $2.59 Million
-15,501 Reduced 3.88%
384,073 $62.2 Million
Q2 2024

Aug 13, 2024

SELL
$144.38 - $157.78 $47 Million - $51.3 Million
-325,243 Reduced 44.87%
399,574 $58.4 Million
Q1 2024

Jun 20, 2024

SELL
$155.22 - $162.74 $5.37 Million - $5.63 Million
-34,577 Reduced 4.55%
724,817 $115 Million
Q4 2023

Feb 13, 2024

SELL
$145.6 - $158.88 $3.06 Million - $3.34 Million
-20,994 Reduced 2.69%
759,394 $119 Million
Q3 2023

Nov 06, 2023

SELL
$155.75 - $174.48 $6.12 Million - $6.86 Million
-39,290 Reduced 4.79%
780,388 $122 Million
Q2 2023

Jul 17, 2023

BUY
$154.35 - $166.11 $162,221 - $174,581
1,051 Added 0.13%
819,678 $136 Million
Q1 2023

Apr 18, 2023

BUY
$151.05 - $180.26 $1.25 Million - $1.49 Million
8,264 Added 1.02%
818,627 $127 Million
Q4 2022

Feb 06, 2023

BUY
$160.2 - $179.79 $4.3 Million - $4.82 Million
26,825 Added 3.42%
810,363 $143 Million
Q3 2022

Oct 25, 2022

BUY
$161.33 - $179.52 $3.9 Million - $4.34 Million
24,188 Added 3.19%
783,538 $128 Million
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $3.97 Million - $4.39 Million
23,586 Added 3.21%
759,350 $135 Million
Q1 2022

May 12, 2022

BUY
$158.14 - $179.59 $2.52 Million - $2.86 Million
15,926 Added 2.21%
735,764 $130 Million
Q4 2021

Feb 15, 2022

SELL
$155.93 - $173.01 $5.34 Million - $5.92 Million
-34,223 Reduced 4.54%
719,838 $123 Million
Q3 2021

Nov 30, 2021

BUY
$161.5 - $179.47 $346,740 - $385,322
2,147 Added 0.29%
754,061 $122 Million
Q2 2021

Aug 17, 2021

BUY
$159.48 - $171.07 $6.28 Million - $6.74 Million
39,407 Added 5.53%
751,914 $124 Million
Q1 2021

Jun 15, 2021

BUY
$153.07 - $170.48 $1.94 Million - $2.16 Million
12,664 Added 1.81%
712,507 $117 Million
Q4 2020

Mar 10, 2021

BUY
$137.11 - $157.38 $1.54 Million - $1.77 Million
11,262 Added 1.64%
699,843 $110 Million
Q3 2020

Dec 21, 2020

BUY
$140.38 - $153.83 $5.21 Million - $5.71 Million
37,119 Added 5.7%
688,581 $103 Million
Q2 2020

Aug 13, 2020

BUY
$128.81 - $155.51 $1.57 Million - $1.9 Million
12,226 Added 1.91%
651,462 $91.6 Million
Q1 2020

Jul 01, 2020

BUY
$111.14 - $153.99 $57,014 - $78,996
513 Added 0.08%
639,236 $83.8 Million
Q4 2019

Feb 18, 2020

BUY
$127.5 - $146.44 $4.19 Million - $4.81 Million
32,856 Added 5.42%
638,723 $93.2 Million
Q3 2019

Nov 12, 2019

BUY
$126.95 - $142.14 $1.7 Million - $1.9 Million
13,378 Added 2.26%
605,867 $78.4 Million
Q2 2019

Aug 15, 2019

BUY
$131.15 - $144.24 $4.75 Million - $5.23 Million
36,240 Added 6.52%
592,489 $82.5 Million
Q1 2019

Jul 31, 2019

BUY
$125.72 - $139.79 $69.3 Million - $77 Million
550,830 Added 10164.79%
556,249 $77.8 Million
Q4 2018

Feb 15, 2019

SELL
$122.84 - $147.84 $65.2 Million - $78.5 Million
-530,863 Reduced 98.99%
5,419 $699,000
Q3 2018

Nov 30, 2018

SELL
$121.58 - $142.88 $9.64 Million - $11.3 Million
-79,328 Reduced 12.89%
536,282 $74.1 Million
Q2 2018

Aug 27, 2018

BUY
$119.4 - $131.76 $1.37 Million - $1.51 Million
11,491 Added 1.9%
615,610 $74.7 Million
Q1 2018

May 14, 2018

BUY
$125.1 - $148.14 $2.4 Million - $2.84 Million
19,171 Added 3.28%
604,119 $77.4 Million
Q4 2017

Feb 16, 2018

BUY
$131.22 - $143.62 $1.68 Million - $1.84 Million
12,822 Added 2.24%
584,948 $81.7 Million
Q3 2017

Nov 06, 2017

BUY
$129.47 - $135.38 $74.1 Million - $77.5 Million
572,126
572,126 $74.4 Million

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $410B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Hm Payson & CO Portfolio

Follow Hm Payson & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hm Payson & CO, based on Form 13F filings with the SEC.

News

Stay updated on Hm Payson & CO with notifications on news.